1+1 > 2: Integration of the Host-directed Traditional Chinese Medicine and the Virus-targeted Modern Medicine in Control of COVID-19

Author(s): Jianjun Sun*

Journal Name: Clinical Cancer Drugs

Volume 7 , Issue 2 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

The COVID-19 pandemic has caused millions of infections and hundreds of thousands deaths in the world. The pandemic is still ongoing and no specific antivirals have been found to control COVID-19. The integration of Traditional Chinese Medicine with supportive measures of Modern Medicine has reportedly played an important role in the control of COVID-19 in China. This review summarizes the evidence of TCM in the treatment of COVID-19 and discusses the plausible mechanism of TCM in control of COVID-19 and other viral infectious diseases.

Keywords: COVID-19, traditional chinese medicine, modern medicine, pandemic, (SARSCoV-2), antivirals.

[1]
Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses 2020; 12(2): 135.
[http://dx.doi.org/10.3390/v12020135 ] [PMID: 31991541]
[2]
Burki TK. Coronavirus in China. Lancet Respir Med 2020; 8(3): 238.
[http://dx.doi.org/10.1016/S2213-2600(20)30056-4 ] [PMID: 32027848]
[3]
Yang G, Zhang H, Yang Y. Challenges and countermeasures of integrative cancer therapy in the epidemic of COVID-19. Integr Cancer Ther 2020; 19: 1534735420912811.
[http://dx.doi.org/10.1177/1534735420912811 ] [PMID: 32178547]
[4]
Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020; 27(3): 325-8.
[http://dx.doi.org/10.1016/j.chom.2020.02.001 ] [PMID: 32035028]
[5]
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[http://dx.doi.org/10.1038/s41586-020-2012-7 ] [PMID: 32015507]
[6]
Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367(6483): 1260-3.
[http://dx.doi.org/10.1126/science.abb2507 ] [PMID: 32075877]
[7]
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020; 63(3): 457-60.
[http://dx.doi.org/10.1007/s11427-020-1637-5 ] [PMID: 32009228]
[8]
Arabi YM, Fowler R, Hayden FG. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med 2020; 46(2): 315-28.
[http://dx.doi.org/10.1007/s00134-020-05943-5 ] [PMID: 32040667]
[9]
Henry BM. COVID-19, ECMO, and lymphopenia: A word of caution. Lancet Respir Med 2020; 8(4): e24.
[http://dx.doi.org/10.1016/S2213-2600(20)30119-3 ] [PMID: 32178774]
[10]
MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. Jama 2020 Apr 7; 323(13): 1245-6.
[http://dx.doi.org/10.1001/jama.2020.2342 ] [PMID: 32074258]
[11]
Chan KW, Wong VT, Tang SCW. covid-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative chinese-western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med 2020; 48(3): 737-62.
[http://dx.doi.org/10.1142/S0192415X20500378 ] [PMID: 32164424]
[12]
Yang Y, Islam M S, Wang J, Li Y, Sci X C I J B. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective biolsciorg 2020; 16 1708-17.
[13]
Du H, Hou X, Miao Y, Huang B, Liu D. Traditional Chinese Medicine: An effective treatment for 2019 novel coronavirus pneumonia. NCP 2020.
[14]
Ren J-L, Zhang A-H, Wang X-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res 2020; 155: 104743.
[http://dx.doi.org/10.1016/j.phrs.2020.104743 ] [PMID: 32145402]
[15]
Luo H, Tang Q-L, Shang Y-X, et al. Can Chinese Medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med 2020; 26(4): 243-50.
[http://dx.doi.org/10.1007/s11655-020-3192-6 ] [PMID: 32065348]
[16]
Luo E, Zhang D, Luo H, et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China. Chin Med 2020; 15: 34-13.
[http://dx.doi.org/10.1186/s13020-020-00317-x ] [PMID: 32308732]
[17]
Ho LTF, Chan KKH, Chung VCH, Leung TH. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19. Eur J Integr Med 2020.: 36101116.
[http://dx.doi.org/10.1016/j.eujim.2020.101116 ] [PMID: 32292529]
[18]
Maxmen A. More than 80 clinical trials launch to test coronavirus treatments. Nature 2020; 578(7795): 347-8.
[http://dx.doi.org/10.1038/d41586-020-00444-3 ] [PMID: 32071447]
[19]
Ye Y-A. G-CHAMPS collaborative group (2020) Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China medRxiv 2020.
[20]
Li Y, Liu X, Guo L, et al. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Syst Rev 2020; 9(1): 75-6.
[http://dx.doi.org/10.1186/s13643-020-01343-4 ] [PMID: 32268923]
[21]
Wang S, Wang Y, Lu Y, Li J, Integrative YSJO. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. Elsevier 2020.
[22]
Ma Y, Chen M, Guo Y, et al. Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. APMIS 2019; 127(5): 372-84.
[http://dx.doi.org/10.1111/apm.12928 ] [PMID: 31124203]
[23]
Liu J, Manheimer E, Shi Y, Gluud C. Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis. J Altern Complement Med 2004; 10(6): 1041-51.
[http://dx.doi.org/10.1089/acm.2004.10.1041 ] [PMID: 15674000]
[24]
World Health Organization - WHO. WHO, Geneva, Switzerland, 2004 SARS: Clinical trials on treatment using a combination of traditional chinese medicine and western medicine 2004.
[25]
Chen Z, Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res 2004; 18(7): 592-4.
[http://dx.doi.org/10.1002/ptr.1485 ] [PMID: 15305324]
[26]
Lau JTF, Leung PC, Wong ELY, et al. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study. J Altern Complement Med 2005; 11(1): 49-55.
[http://dx.doi.org/10.1089/acm.2005.11.49 ] [PMID: 15750363]
[27]
Leung P-C. The efficacy of Chinese medicine for SARS: A review of Chinese publications after the crisis. Am J Chin Med 2007; 35(4): 575-81.
[http://dx.doi.org/10.1142/S0192415X07005077 ] [PMID: 17708624]
[28]
Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst. Rev. 2012.: 10CD004882 .
[http://dx.doi.org/10.1002/14651858.CD004882.pub3] [PMID: 23076910]
[29]
Xiu-hui L, Jian-hua H, Ke Z, Jun Y, Chun-yan G. Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets. Chin J Integr Med 2003; 9: 263-5.
[http://dx.doi.org/10.1007/BF02838611]
[30]
Rong-bing W, Jun-min L, Yu-yong J, et al. Therapeutic effects of integrated traditional Chinese medicine and western medicine in treating severe acute respiratory syndrome. Chin J Integr Med 2003; 9: 259-62.
[http://dx.doi.org/10.1007/BF02838610]
[31]
Tong X, Li A, Zhang Z, et al. TCM treatment of infectious atypical pneumonia--a report of 16 cases. J Tradit Chin Med 2004; 24(4): 266-9.
[PMID: 15688692 ]
[32]
Lau TF, Leung PC, Wong ELY, et al. Using herbal medicine as a means of prevention experience during the SARS crisis. Am J Chin Med 2005; 33(3): 345-56.
[http://dx.doi.org/10.1142/S0192415X05002965 ] [PMID: 16047553]
[33]
Xinhuanet Press Conference of the Joint Prevention and Control Mechanism of the State Council Xinhuanet 2020.
[34]
National Health Commission NHC of the PRC; Administration of Traditional Chinese Medicine of the PRC.. 2020.Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia V7
[35]
Xinhuanet (2020) Press Conference of the Joint Prevention and Control Mechanism of the State Council, Feb 17, 2020 Xinhuanet 2020.
[36]
Xinhuanet (2020) Press Conference of the Joint Prevention and Control Mechanism of the State Council, Mar 17, 2020 Xinhuanet 2020.
[37]
Xinhuanet (2020) Press Conference of the Joint Prevention and Control Mechanism of the State Council, Mar 23, 2020 Xinhuanet 2020.
[38]
Chen Y, Zhang JJ, Liu Y, Shang HC. Comprehensive comparison and analysis of the prevention and treatment of coronavirus disease 2019 and severe acute respiratory syndrome with traditional. World J Tradit Chin Med 2020.
[39]
Wang Z, Chen X, Lu Y, Chen F, Zhang W. 2020; Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 14.
[http://dx.doi.org/10.5582/bst.2020.01030]
[40]
Wang Z, Li L, Yan J, Yao Y. Evaluating the Traditional Chinese Medicine (TCM) officially recommended in China for COVID-19 using ontology-based side-effect prediction framework (OSPF) and Deep Learning 2020.
[41]
Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China. J Med Virol 2020.: 25200230.
[http://dx.doi.org/10.1002/jmv.25733]
[42]
Ling C-Q. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). J Integr Med 2020; 18(2): 87-8.
[http://dx.doi.org/10.1016/j.joim.2020.02.004 ] [PMID: 32122812]
[43]
National Health Commission NHC of PRC, National administration of traditional Chinese medicine of the PRC (2020). Guidance for Corona Virus Disease 2020.
[44]
Zhang J, Litvinova M, Wang W, et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: A descriptive and modelling study. Lancet Infect Dis 2020.S1473-3099(20)30230-9
[http://dx.doi.org/10.1016/S1473-3099(20)30230-9] [PMID: 32247326]
[45]
Azman AS, Luquero FJ. From China: hope and lessons for COVID- 19 control. Lancet Infect Dis 2020.S1473-3099(20)30264-4
[http://dx.doi.org/10.1016/S1473-3099(20)30264-4] [PMID: 32251637]
[46]
Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ 2020; 27(5): 1451-4.
[http://dx.doi.org/10.1038/s41418-020-0530-3 ] [PMID: 32205856]
[47]
Xu K, Cai H, Shen Y, et al. Management of corona virus disease-19 (COVID-19): The Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020; 49.
[48]
Wu H, Tian J, Dai D, et al. Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome. BMJ Open Diabetes Res Care 2020; 8(1): e001181.
[http://dx.doi.org/10.1136/bmjdrc-2020-001181 ] [PMID: 32220922]
[49]
Li Y, Sui X, Su Z, et al. Meta-analysis of paclitaxel-based chemotherapy combined with traditional Chinese medicines for gastric cancer treatment. Front Pharmacol 2020; 11: 132.
[http://dx.doi.org/10.3389/fphar.2020.00132 ] [PMID: 32174834]
[50]
Li R, Li Q, Ji Q. Molecular targeted study in tumors: From western medicine to active ingredients of traditional Chinese medicine. Biomed Pharmacother 2020.: 121109624.
[http://dx.doi.org/10.1016/j.biopha.2019.109624 ] [PMID: 31733579]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 2
Year: 2020
Published on: 23 June, 2020
Page: [89 - 94]
Pages: 6
DOI: 10.2174/2212697X07999200623130743
Price: $25

Article Metrics

PDF: 265
HTML: 2